UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 7313: Risk assessment, early detection, and strategic prevention of naturally occurring cancers in companion dogs

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.7313-7313

2024

Volltextzugriff (PDF)

Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA

Immuno, 2023-06, Vol.3 (2), p.237-249

2023

Volltextzugriff (PDF)

Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings

Molecular cancer therapeutics, 2023-03, Vol.22 (3), p.371-380

2023

Volltextzugriff (PDF)

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

Frontiers in immunology, 2023-02, Vol.14, p.1060905-1060905

2023

Volltextzugriff (PDF)

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia

Molecular therapy, 2021-12, Vol.29 (12), p.3410-3421

2021

Volltextzugriff (PDF)

Susceptibility to Immune Elimination of Epithelial and Quasi-mesenchymal Pancreatic Ductal Adenocarcinoma Cells under Basal Conditions and Following Treatment with FOLFIRINOX

Journal of the American College of Surgeons, 2021-11, Vol.233 (5), p.S154-S155

2021

Volltextzugriff (PDF)

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer

Cancers, 2021-08, Vol.13 (16), p.3994

2021

Volltextzugriff (PDF)

A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells

Leukemia, 2021-06, Vol.35 (6), p.1586-1596

2021

Volltextzugriff (PDF)

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Blood advances, 2021-02, Vol.5 (4), p.1069-1080

2021

Volltextzugriff (PDF)

Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma

Veterinary & comparative oncology, 2020-12, Vol.18 (4), p.664-674

2020

Volltextzugriff (PDF)

GTB-3550 TriKE™ for the Treatment of High-Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML) Safely Drives Natural Killer (NK) Cell Proliferation At Initial Dose Cohorts

Blood, 2020-11, Vol.136 (Supplement 1), p.7-8

2020

Volltextzugriff (PDF)

470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A500-A500

2020

Volltextzugriff (PDF)

Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML

Blood advances, 2020-10, Vol.4 (20), p.5118-5132

2020

Volltextzugriff (PDF)

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

Cancers, 2020-09, Vol.12 (9), p.2659

2020

Volltextzugriff (PDF)

Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager

Cancer immunology research, 2020-09, Vol.8 (9), p.1139-1149

2020

Volltextzugriff (PDF)

Abstract 4592: Early detection for strategic prevention of a terminal canine cancer: A model to reduce the impact of cancer in our society

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4592-4592

2020

Volltextzugriff (PDF)

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors

Biomolecules (Basel, Switzerland), 2020-06, Vol.10 (6), p.956

2020

Volltextzugriff (PDF)

Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy in Dogs with Splenic Hemangiosarcoma

Veterinary & comparative oncology, 2020-04, Vol.18 (4), p.664-674

2020

Volltextzugriff (PDF)

Le Nouveau Festin de Pierre, ou l’Athée Foudroyé: Édition, notes et présentation par Daniela Dalla Valle

2020

Volltextzugriff (PDF)

Acte I

2020

Volltextzugriff (PDF)

Acte II. 19

2020

Volltextzugriff (PDF)

Acte IV

2020

Volltextzugriff (PDF)

Le nouveau festin de Pierre, ou l'Athée Foudroyé

1. ed., 2020

Volltextzugriff (PDF)

Acte V. 77

2020

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(244)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(151)
Life Sciences & Biomedicine
(145)
Animals
(122)
Mice
(110)
Humans
(96)
Biological And Medical Sciences
(78)
Medical Sciences
(71)
Mice, Inbred C57bl
(54)
Oncology
(54)
Female
(44)
Hematology
(42)
Bone Marrow Transplantation
(37)
Immunology
(34)
Immunotoxin
(32)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(31)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(31)
Male
(30)
Mice, Inbred Balb C
(30)
Cell Line, Tumor
(29)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog Model

Abstract 7313: Risk assessment, early detection, and strategic prevention of naturally occurring cancers in companion dogs

Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA

Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia

Susceptibility to Immune Elimination of Epithelial and Quasi-mesenchymal Pancreatic Ductal Adenocarcinoma Cells under Basal Conditions and Following Treatment with FOLFIRINOX

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer

A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma

GTB-3550 TriKE™ for the Treatment of High-Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML) Safely Drives Natural Killer (NK) Cell Proliferation At Initial Dose Cohorts

470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors

Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager

Abstract 4592: Early detection for strategic prevention of a terminal canine cancer: A model to reduce the impact of cancer in our society

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors

Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy in Dogs with Splenic Hemangiosarcoma

Le Nouveau Festin de Pierre, ou l’Athée Foudroyé: Édition, notes et présentation par Daniela Dalla Valle

Acte I

Acte II. 19

Acte IV

Le nouveau festin de Pierre, ou l'Athée Foudroyé

Acte V. 77

Suchergebnisse filtern